Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer

被引：0
|
作者：
TJ Polascik
JD Pearson
AW Partin
Dr TJ Polascik
机构：
[1] James Buchanan Brady Urological Institute,
[2] The Johns Hopkins Medical Institutions,undefined
[3] Merck Research Laboratories,undefined
来源：
Prostate Cancer and Prostatic Diseases | 1998年 / 1卷
关键词：
prostate cancer; PSA; multivariate analysis; nomogram; staging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To benefit from definitive local therapy, men with clinically localized prostate cancer should have organ-confined disease. We discuss the use of multivariate analysis using serum PSA, biopsy Gleason score and clinical stage to improve the prediction of pathologic stage.
引用
收藏
页码：301 / 306
页数：5
相关论文
共 50 条
  • [1] Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer
    Polascik, TJ
    Pearson, JD
    Partin, AW
    PROSTATE CANCER AND PROSTATIC DISEASES, 1998, 1 (06) : 301 - 306
  • [2] Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men
    Song, C
    Kang, TJ
    Ro, JY
    Lee, MS
    Kim, CS
    Ahn, HJ
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (02) : 262 - 266
  • [3] Testosterone as a predictor of pathologic stage in clinically localized prostate cancer
    Isom-Batz, G
    Bianco, FJ
    Kattan, MW
    Mulhall, JP
    Eastham, JA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 384 - 385
  • [4] The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer
    Pannek, J
    Subong, ENP
    Jones, KA
    Marschke, PLS
    Epstein, JI
    Chan, DW
    Carter, HB
    Luderer, AA
    Partin, AW
    UROLOGY, 1996, 48 (6A) : 51 - 54
  • [5] Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
    Thiel, R
    Pearson, JD
    Epstein, JI
    Walsh, PC
    Carter, HB
    UROLOGY, 1997, 49 (05) : 716 - 720
  • [6] Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer
    Hasannejadasl, Hajar
    Roumen, Cheryl
    van der Poel, Henk
    Vanneste, Ben
    van Roermund, Joep
    Aben, Katja
    Kalendralis, Petros
    Osong, Biche
    Kiemeney, Lambertus
    Van Oort, Inge
    Verwey, Renee
    Hochstenbach, Laura
    Bloemen-van Gurp, Esther J.
    Dekker, Andre
    Fijten, Rianne R. R.
    PLOS ONE, 2023, 18 (03):
  • [7] Value of percent free prostate-specific antigen for the prediction of pathological stage in men with clinically localized prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Serrallach, F
    Abascal, JM
    H'Mammed, YI
    de Torres, IM
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (04): : 239 - 243
  • [8] USE OF MULTIVARIATE MODELS TO IMPROVE PROSTATE CANCER DETECTION
    Stephan, C.
    Cammann, H.
    Lein, M.
    Schrader, M.
    Dever, S.
    Miller, K.
    Jung, K.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3498 - 3498
  • [9] The use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer; Preliminary report
    Goto, Y
    Ohori, M
    Arakawa, A
    Kattan, M
    Wheeler, TM
    Scardino, PT
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1365 - 1369
  • [10] The use of "intact" PSA (PSA-1) in the prediction of organ-confined disease and pathologic stage of clinically localized prostate cancer.
    Steuber, T
    Nurmikko, P
    Haese, A
    Petterson, K
    Graefen, M
    Hammerer, P
    Huland, H
    Lilja, H
    JOURNAL OF UROLOGY, 2002, 167 (04): : 226 - 226
12345